These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17302281)

  • 1. [Molecular imaging of psychiatric disorders].
    Takahashi H; Suhara T
    Nihon Rinsho; 2007 Feb; 65(2):336-41. PubMed ID: 17302281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Distribution and function of dopamine D1, D2 receptor].
    Suhara T; Miyoshi M
    Rinsho Shinkeigaku; 2007 Nov; 47(11):826-8. PubMed ID: 18210808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET radioligands for the dopamine D1-receptor: Application in psychiatric disorders.
    Cervenka S
    Neurosci Lett; 2019 Jan; 691():26-34. PubMed ID: 29518542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands.
    Farde L; Hall H
    Arzneimittelforschung; 1992 Feb; 42(2A):260-4. PubMed ID: 1316756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of radioligands in schizophrenia research.
    Sedvall G; Farde L; Hall H; Halldin C; Karlsson P; Nordström AL; Nyberg S; Pauli S
    Clin Neurosci; 1995; 3(2):112-21. PubMed ID: 7583617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
    Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
    Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography.
    Ito H; Takahashi H; Arakawa R; Takano H; Suhara T
    Neuroimage; 2008 Jan; 39(2):555-65. PubMed ID: 17962043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vivo evaluation of expressed protein function by PET].
    Matsumoto R; Suhara T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):137-41. PubMed ID: 16045196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in PET scan imaging of neuroreceptors in schizophrenia.
    Sedvall G; Pauli S; Farde L; Karlsson P; Nyberg S; Nordström AL
    Isr J Psychiatry Relat Sci; 1995; 32(1):22-9. PubMed ID: 7622344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current status of PET scanning with respect to schizophrenia.
    Sedvall G
    Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the time-course of dopamine D2 receptor occupancy in living human brain from plasma pharmacokinetics of antipsychotics.
    Takano A; Suhara T; Ikoma Y; Yasuno F; Maeda J; Ichimiya T; Sudo Y; Inoue M; Okubo Y
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):19-26. PubMed ID: 14764214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Theory in antipsychotic drug therapy for schizophrenia].
    Tomioka S; Ishigooka J
    Seishin Shinkeigaku Zasshi; 2006; 108(6):614-8. PubMed ID: 16910539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.
    Mamo D; Kapur S; Shammi CM; Papatheodorou G; Mann S; Therrien F; Remington G
    Am J Psychiatry; 2004 May; 161(5):818-25. PubMed ID: 15121646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
    Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
    Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal and extrastriatal dopamine D2 receptor occupancy by a novel antipsychotic, blonanserin: a PET study with [11C]raclopride and [11C]FLB 457 in schizophrenia.
    Tateno A; Arakawa R; Okumura M; Fukuta H; Honjo K; Ishihara K; Nakamura H; Kumita S; Okubo Y
    J Clin Psychopharmacol; 2013 Apr; 33(2):162-9. PubMed ID: 23422369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography shows reduced striatal dopamine D1 but not D2 receptors in juvenile neuronal ceroid lipofuscinosis.
    Rinne JO; Ruottinen HM; Någren K; Aberg LE; Santavuori P
    Neuropediatrics; 2002 Jun; 33(3):138-41. PubMed ID: 12200743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: an open-label study in patients with schizophrenia.
    Mamo D; Kapur S; Keshavan M; Laruelle M; Taylor CC; Kothare PA; Barsoum P; McDonnell D
    Neuropsychopharmacology; 2008 Jan; 33(2):298-304. PubMed ID: 17443131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia.
    Hirvonen J; van Erp TG; Huttunen J; Någren K; Huttunen M; Aalto S; Lönnqvist J; Kaprio J; Cannon TD; Hietala J
    Psychiatry Res; 2006 Jan; 146(1):13-20. PubMed ID: 16361088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.